These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions. Popescu BF; Guo Y; Jentoft ME; Parisi JE; Lennon VA; Pittock SJ; Weinshenker BG; Wingerchuk DM; Giannini C; Metz I; Brück W; Shuster EA; Carter J; Boyd CD; Clardy SL; Cohen BA; Lucchinetti CF Neurology; 2015 Jan; 84(2):148-58. PubMed ID: 25503621 [TBL] [Abstract][Full Text] [Related]
9. Clinical and MRI phenotype of children with MOG antibodies. Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801 [TBL] [Abstract][Full Text] [Related]
10. Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders. Frederick MC; Cameron MH Curr Neurol Neurosci Rep; 2016 Mar; 16(3):26. PubMed ID: 26847090 [TBL] [Abstract][Full Text] [Related]
11. The pathological spectrum of CNS inflammatory demyelinating diseases. Hu W; Lucchinetti CF Semin Immunopathol; 2009 Nov; 31(4):439-53. PubMed ID: 19779719 [TBL] [Abstract][Full Text] [Related]
12. Antibody biomarkers in CNS demyelinating diseases - a long and winding road. Berger T; Reindl M Eur J Neurol; 2015 Aug; 22(8):1162-8. PubMed ID: 26010364 [TBL] [Abstract][Full Text] [Related]
13. Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study. Mariotto S; Ferrari S; Monaco S; Benedetti MD; Schanda K; Alberti D; Farinazzo A; Capra R; Mancinelli C; De Rossi N; Bombardi R; Zuliani L; Zoccarato M; Tanel R; Bonora A; Turatti M; Calabrese M; Polo A; Pavone A; Grazian L; Sechi G; Sechi E; Urso D; Delogu R; Janes F; Deotto L; Cadaldini M; Bianchi MR; Cantalupo G; Reindl M; Gajofatto A J Neurol; 2017 Dec; 264(12):2420-2430. PubMed ID: 29063242 [TBL] [Abstract][Full Text] [Related]
14. [Diagnostic criteria of borderline forms of multiple sclerosis]. Dupel-Pottier C Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):935-43. PubMed ID: 11787358 [TBL] [Abstract][Full Text] [Related]
15. Distinct microglial and macrophage distribution patterns in the concentric and lamellar lesions in Baló's disease and neuromyelitis optica spectrum disorders. Hayashida S; Masaki K; Suzuki SO; Yamasaki R; Watanabe M; Koyama S; Isobe N; Matsushita T; Takahashi K; Tabira T; Iwaki T; Kira JI Brain Pathol; 2020 Nov; 30(6):1144-1157. PubMed ID: 32902014 [TBL] [Abstract][Full Text] [Related]
16. Relapsing optic neuritis and meningoencephalitis in a child: case report of delayed diagnosis of MOG-IgG syndrome. Zhong X; Chang Y; Tan S; Wang J; Sun X; Wu A; Peng L; Lau AY; Kermode AG; Qiu W BMC Neurol; 2019 May; 19(1):94. PubMed ID: 31072329 [TBL] [Abstract][Full Text] [Related]
17. Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases. Baumann M; Hennes EM; Schanda K; Karenfort M; Kornek B; Seidl R; Diepold K; Lauffer H; Marquardt I; Strautmanis J; Syrbe S; Vieker S; Höftberger R; Reindl M; Rostásy K Mult Scler; 2016 Dec; 22(14):1821-1829. PubMed ID: 26869530 [TBL] [Abstract][Full Text] [Related]
18. MOG antibody-associated demyelinating disease mimicking typical multiple sclerosis: A case for expanding anti-MOG testing? Breza M; Koutsis G; Tzartos JS; Velonakis G; Evangelopoulos ME; Tzanetakos D; Karagiorgou K; Angelopoulou G; Kasselimis D; Potagas C; Anagnostouli M; Stefanis L; Kilidireas C Mult Scler Relat Disord; 2019 Aug; 33():67-69. PubMed ID: 31158804 [TBL] [Abstract][Full Text] [Related]
20. Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese. Chan KH; Lee R; Lee JC; Tse AC; Pang SY; Lau GK; Teo KC; Ho PW J Neuroimmunol; 2013 Sep; 262(1-2):100-5. PubMed ID: 23838529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]